Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
67.72
-0.14 (-0.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
45
46
Next >
Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities
October 19, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Why AstraZeneca's Disappointing Lung Cancer Update Also Tripped Gilead Stock
October 18, 2023
The companies are hoping to use antibody drug conjugates in lung cancer patients.
Via
Investor's Business Daily
Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program
October 18, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
October 17, 2023
Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!
Via
InvestorPlace
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
October 13, 2023
Via
Benzinga
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
October 05, 2023
Via
Benzinga
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why
October 17, 2023
Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership.
Via
Benzinga
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
October 17, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead and Kite Oncology Present Important New Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
October 16, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023
October 16, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
How Is The Market Feeling About Gilead Sciences?
September 21, 2023
Via
Benzinga
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
October 15, 2023
These companies aren't getting the respect they deserve.
Via
The Motley Fool
Gilead Sciences to Release Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
October 12, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
5 Reasons Gilead Sciences is a Better Buy Than You Think
October 10, 2023
Gilead Sciences is a value and high-yielding stock on the brink of a stock rebound that could add double-digits to investors portfolios this year an next.
Via
MarketBeat
Exposures
COVID-19
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip
October 10, 2023
Wall Street price targets suggest this stock can rocket more than 400% higher.
Via
The Motley Fool
Gilead Sciences Unusual Options Activity
September 20, 2023
Via
Benzinga
Biotech Sector: On The Verge Of Triumph Or Turmoil?
October 06, 2023
In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise.
Via
Talk Markets
5 Low Beta, High-Yield Stocks for Your Low-Risk Income Portfolio
October 05, 2023
Low-beta stocks offer protection against market downturns and can lead to market-beating performance for investors; high yield helps
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Pharma Giants Combine Forces to Fight New M&A Rules
October 04, 2023
Some of pharma's biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Via
The Motley Fool
Gilead to Present Latest Innovative Virology Data on Current and Potentially Transformative Therapies Across HIV and COVID-19 at IDWeek 2023
October 03, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.
Via
InvestorPlace
Gilead Board Director Kevin E. Lofton Named to List of Influential Leaders
October 02, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
These stocks come with great dividends and more.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Two Trial Halts In A Row - Gilead Sciences Stops Late Stage COVID-19 Study
September 28, 2023
Gilead Sciences Inc (NASDAQ: GILD) said it has
Via
Benzinga
Exposures
COVID-19
Gilead Sciences Adapts to Economic Shifts to Support Investor Confidence
September 28, 2023
By the end of today, September 28, 2023, Gilead Sciences (NASDAQ:GILD) is set to deliver a dividend payout of $0.75 per share, equating to an annualized dividend yield of 3.96%.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Gilead Sciences Inc. (NASDAQ: GILD) Making Surprising Moves in Tuesday Session
September 26, 2023
Via
Investor Brand Network
Exposures
COVID-19
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
September 21, 2023
Many stocks have nosebleed valuations. But not these.
Via
The Motley Fool
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Hepatic Impairment
September 19, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
45
46
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.